Campbell & Co. Investment Adviser »

Cytek Biosciences shares owned by Campbell & Co. Investment Adviser

Quarter-by-quarter ownership of Cytek Biosciences (CTKB) shares owned by Campbell & Co. Investment Adviser from 13F filings

Historical chart of Campbell & Co. Investment Adviser investment in Cytek Biosciences

Tip: Access up to 7 years of quarterly data

All positions including Cytek Biosciences held by Campbell & Co. Investment Adviser consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Cytek Biosciences by Campbell & Co. Investment Adviser

Quarter filed Position value Share count Share price at filing
2026-06-30 $174k 39k 4.43

More positions owned by Campbell & Co. Investment Adviser

Hilton Worldwide Holdings Common Stock (HLT)
Petroleo Brasileiro SA - Petro Adr (PBR)
Darling Ingredients Common Stock (DAR)
Hartford Insurance Group Inc/T Common Stock (HIG)
Atmos Energy Corp Common Stock (ATO)
Marriott International Common Stock (MAR)
LyondellBasell Industries NV Common Stock (LYB)
Westlake Corp Common Stock (WLK)
Mettler-Toledo International I Common Stock (MTD)
Labcorp Holdings Common Stock (LH)
Loews Corp Common Stock (L)
US Bancorp Common Stock (USB)
Primerica Common Stock (PRI)
Mastercard Common Stock (MA)
Wells Fargo & Co Common Stock (WFC)

View all positions for Campbell & Co. Investment Adviser

Top funds holding Cytek Biosciences

BlackRock
Millennium Management
Robeco Investment Management
Hillhouse Capital Advisors
Vanguard Capital Management
State Street Corporation
Geode Capital Management
Dimensional Fund Advisors
Goldman Sachs Group
Royce & Associates
Morgan Stanley
Russell Investments
Acadian Asset Management
Bank of America Corporation
Vanguard Portfolio Management

View all funds holding Cytek Biosciences